Systematic review with meta‐analysis : risk factors for non‐alcoholic fatty liver disease suggest a shared altered metabolic and cardiovascular profile between lean and obese patients
Systematic review with meta‐analysis : endoscopic dilation is highly effective and safe in children and adults with eosinophilic oesophagitis
Systematic review with meta‐analysis : the efficacy of vonoprazan‐based triple therapy on Helicobacter pylori eradication
Systematic review : interventions for abdominal pain management in inflammatory bowel disease
Review article : hepatitis E—a concise review of virology, epidemiology, clinical presentation and therapy
Azathioprine dose reduction in inflammatory bowel disease patients on combination therapy : an open‐label, prospective and randomised clinical trial
Infliximab and adalimumab drug levels in Crohn's disease : contrasting associations with disease activity and influencing factors
The benefit of combination therapy depends on disease phenotype and duration in Crohn's disease
Immune modulator therapy for microscopic colitis in a case series of 73 patients
Significant positive association of endotoxemia with histological severity in 237 patients with non‐alcoholic fatty liver disease
Patients with cirrhosis who have coronary artery disease treated with cardiac stents have high rates of gastrointestinal bleeding, but no increased mortality
Editorial : tackling hepatorenal syndrome—terlipressin for all, or time for a stratified approach?
Editorial : which iron preparation for patients with IBD?
Editorial : which iron preparation for patients with IBD? Authors’ reply
Editorial : is ribavirin needed in the treatment of post‐transplant hepatitis C recurrence?
Editorial : when to be suspicious of malignancy‐associated pseudoachalasia
Editorial : lower gastrointestinal bleeding and low‐dose aspirin
Editorial : lower gastrointestinal bleeding and low‐dose aspirin—authors’ reply
Editorial : yoga for QoL in ulcerative colitis—any better than other supportive activities?
Editorial : yoga for QoL in ulcerative colitis—any better than other supportive activities? Authors’ reply
Editorial : refractory GERD—good drug, wrong patients?
Editorial : refractory GERD—good drug, wrong patients? Authors’ reply
Editorial : does disease extension lead to disease progression in proctitis?
Editorial : food for thought—the low‐FODMAP diet and IBS in perspective
Letter : the influence of direct acting agents for hepatitis C, on hepatitis B reactivation
Letter : the efficacy of oltipraz in patients with non‐alcoholic fatty liver disease has not been confirmed
Letter : the efficacy of oltipraz in patients with non‐alcoholic fatty liver disease has not been confirmed—authors’ reply
Letter : HBV/HCV coinfection in the era of direct‐acting antivirals
Letter : anti‐TNF dose de‐escalation in Crohn's disease—a case‐by‐case decision